Chlamydia trachomatis and Mycoplasma genitalium Plasma Antibodies in Relation to Epithelial Ovarian Tumors
Clinical characteristics of women with type II tumors and plasma samples drawn 1.3–5.1 years prior to diagnosis.
Type II tumors with prospective plasma samples ()
Oral contraceptive pill use ≥1 yeara
Past or current HRT use
Past or current smoking
History of PID
Serous ovarian cancer
Mixed epithelial ovarian cancer
Undifferentiated ovarian cancer
Values are presented as medians and range (minimum and maximum values of age, menarche, menopause, parity, and BMI); or number and percentage of patients in each group (0 children, ≥3 children, oral contraceptive pill use ≥1 year, past or current HRT use, past or current smoking, history of PID). HRT: hormone replacement therapy; PID: pelvic inflammatory disease; BMI: body mass index; SSPC: Serous Surface Papillary Carcinoma.
aMissing data in one case.